Premium
Issue Information
Author(s) -
JunPing Liu,
Jerzy Bełtowski,
Daniel C. Chan,
Hui Y. Lan,
Feng Liu,
San Antonio,
Alyson A. Miller,
Chin Siang Ong,
Sonia Saad,
David G. Allen
Publication year - 2020
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.13115
Subject(s) - salidroside , dosing , pharmacogenetics , medicine , pharmacology , diabetes mellitus , inflammatory bowel diseases , intensive care medicine , endocrinology , biology , inflammatory bowel disease , biochemistry , disease , genotype , gene
In this Issue:Statin therapy and cardiovascular risk Glucagon‐like peptides in bowel infl ammation H1N1 virus and immunodepression Preemptive pharmacogenetics in drug dosing COVID‐19: potential therapy with retinoids Salidroside for diabetes in TGF‐β & β‐catenin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom